Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 8:41 AM UTC
| NCT Number | NCT07621718 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 670 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | October 13, 2026 (4 days ago) |
As of October 17, 2026: Clinical trial NCT07621718 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 18 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07621718 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07621718 was last updated 4 days ago (October 13, 2026). HelloStudys verifies this status automatically.